These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 35003282)
1. Hypertension Management in Patients with Chronic Kidney Disease in the Post-SPRINT Era. Jung HH Electrolyte Blood Press; 2021 Dec; 19(2):19-28. PubMed ID: 35003282 [TBL] [Abstract][Full Text] [Related]
2. Blood pressure control in patients with chronic kidney disease. Lee JY; Han SH Korean J Intern Med; 2021 Jul; 36(4):780-794. PubMed ID: 34153181 [TBL] [Abstract][Full Text] [Related]
3. Treatment of Hypertension: Which Goal for Which Patient? Jarraya F Adv Exp Med Biol; 2017; 956():117-127. PubMed ID: 27722961 [TBL] [Abstract][Full Text] [Related]
4. Blood pressure targets for hypertension in people with diabetes mellitus. Arguedas JA; Leiva V; Wright JM Cochrane Database Syst Rev; 2013 Oct; (10):CD008277. PubMed ID: 24170669 [TBL] [Abstract][Full Text] [Related]
5. Relationship between blood pressure and kidney diseases in large randomized controlled trials: secondary analyses using SPRINT and ACCORD-BP trials. Wang L; Pezeshkian K; Rayamajhi S; Herzallah K; Al-Abcha A; Olomu A; Kelly-Blake K; Yu E; Wang DH J Hum Hypertens; 2021 Oct; 35(10):859-869. PubMed ID: 33093616 [TBL] [Abstract][Full Text] [Related]
11. SPRINT and the Kidney: What Have We Learned? Wells R; Rahman M Curr Hypertens Rep; 2018 Sep; 20(11):95. PubMed ID: 30218213 [TBL] [Abstract][Full Text] [Related]
12. Blood pressure targets in patients with chronic kidney disease: MDRD and AASK now confirming SPRINT. Sarafidis P; Loutradis C; Ortiz A; Ruilope LM Clin Kidney J; 2020 Jun; 13(3):287-290. PubMed ID: 32699614 [TBL] [Abstract][Full Text] [Related]
14. Effects of blood pressure lowering on outcome incidence in hypertension: 7. Effects of more vs. less intensive blood pressure lowering and different achieved blood pressure levels - updated overview and meta-analyses of randomized trials. Thomopoulos C; Parati G; Zanchetti A J Hypertens; 2016 Apr; 34(4):613-22. PubMed ID: 26848994 [TBL] [Abstract][Full Text] [Related]
15. 2015 guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the management of hypertension. Chiang CE; Wang TD; Ueng KC; Lin TH; Yeh HI; Chen CY; Wu YJ; Tsai WC; Chao TH; Chen CH; Chu PH; Chao CL; Liu PY; Sung SH; Cheng HM; Wang KL; Li YH; Chiang FT; Chen JH; Chen WJ; Yeh SJ; Lin SJ J Chin Med Assoc; 2015 Jan; 78(1):1-47. PubMed ID: 25547819 [TBL] [Abstract][Full Text] [Related]
16. BP Targets in Hypertension: What Should We Do Now That SPRINT Is Out? Bhatt H; Ghazi L; Calhoun D; Oparil S Curr Cardiol Rep; 2016 Oct; 18(10):98. PubMed ID: 27566331 [TBL] [Abstract][Full Text] [Related]
17. Blood pressure management in hypertensive people with non-dialysis chronic kidney disease in Queensland, Australia. Zhang J; Healy HG; Venuthurupalli SK; Tan KS; Wang Z; Cameron A; Hoy WE BMC Nephrol; 2019 Sep; 20(1):348. PubMed ID: 31484506 [TBL] [Abstract][Full Text] [Related]
18. What Is Wrong with the Blood Pressure Target Recommendation of KDIGO 2021 for Hypertension in Chronic Kidney Disease? Jamale T; Kulkarni M; Keskar V Nephron; 2023; 147(10):616-620. PubMed ID: 37231907 [TBL] [Abstract][Full Text] [Related]
19. Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial). Soliman EZ; Ambrosius WT; Cushman WC; Zhang ZM; Bates JT; Neyra JA; Carson TY; Tamariz L; Ghazi L; Cho ME; Shapiro BP; He J; Fine LJ; Lewis CE; Circulation; 2017 Aug; 136(5):440-450. PubMed ID: 28512184 [TBL] [Abstract][Full Text] [Related]